Intrinsic Edge Capital Management LLC Twist Bioscience Corp Transaction History

Intrinsic Edge Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$27.95 - $53.0 $2.72 Million - $5.15 Million	97,209 Added 97.21%	197,209 $9.72 Million
Q1 2024 May 14, 2024	BUY	$32.28 - $41.5 $3.23 Million - $4.15 Million	100,000 New	100,000 $3.43 Million
Q4 2021 Feb 14, 2022	SELL	$75.47 - $135.88 $2.54 Million - $4.57 Million	-33,659 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$95.64 - $131.48 $1.34 Million - $1.84 Million	-14,000 Reduced 29.38%	33,659 $3.6 Million
Q2 2021 Aug 16, 2021	BUY	$88.13 - $142.06 $1.32 Million - $2.13 Million	15,000 Added 45.93%	47,659 $6.35 Million
Q4 2020 Feb 16, 2021	SELL	$76.64 - $167.89 $6.19 Million - $13.6 Million	-80,769 Reduced 71.21%	32,659 $4.61 Million
Q3 2020 Nov 16, 2020	BUY	$45.46 - $78.79 $5.16 Million - $8.94 Million	113,428 New	113,428 $8.62 Million
Q1 2020 May 15, 2020	SELL	$19.71 - $35.15 $1.57 Million - $2.8 Million	-79,689 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$21.0 - $26.48 $3.79 Million - $4.77 Million	-180,311 Reduced 69.35%	79,689 $1.67 Million
Q3 2019 Nov 14, 2019	BUY	$23.72 - $33.99 $6.17 Million - $8.84 Million	260,000 New	260,000 $6.21 Million

255

66.8M

82.8K

45.4K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.2B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Intrinsic Edge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Intrinsic Edge Capital Management LLC with notifications on news.